Literature DB >> 16936439

Effects of MCI-186 (edaravone), a novel free radical scavenger, upon experimental atherosclerosis in apolipoprotein E-deficient mice.

Taka-aki Okabe1, Chiharu Kishimoto, Kana Shimada, Toshinori Murayama, Masayuki Yokode, Toru Kita.   

Abstract

BACKGROUND: Recent evidence suggests that oxidative stress may play a role in the development of atherosclerosis. MCI-186 (3-methyl-1-phenyl-1-phyrazolin-5-one, edaravone) is a novel free radical scavenger, but it remains unclear whether free radical scavengers would be effective for the prevention of the disease. METHODS AND
RESULTS: Experimental atherosclerosis was induced in apolipoprotein E-deficient mice fed a high-fat diet containing 0.3% cholesterol. Mice were treated with an intraperitoneal injection of either MCI-186 1 mg/kg per day or MCI-186 10 mg/kg per day on alternate days over 4 weeks. Fatty streak lesion was suppressed by MCI-186 10 mg/kg per day administration, but not by mg/kg per day. Immunohistochemical analysis showed that macrophage and CD4+ T-cell accumulation and oxidative stress overload in the fatty streak lesion were suppressed in mice that received MCI-186 treatment.
CONCLUSIONS: MCI-186 administration suppressed the development of atherosclerosis, associated with reduced expression of both immune-activated cells and oxidative stress in fatty streak plaques.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16936439     DOI: 10.1253/circj.70.1216

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  4 in total

1.  Suppression of postoperative intimal hyperplasia of vein grafts with edaravone in rat models - a scanning electron microscope study.

Authors:  Mitsuhiro Yamamura; Yuji Miyamoto; Masataka Mitsuno; Hiroe Tanaka; Yasuhiko Kobayashi; Masaaki Ryomoto
Journal:  Int J Angiol       Date:  2007

Review 2.  The efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular disease.

Authors:  Kiyoshi Kikuchi; Salunya Tancharoen; Nobuyuki Takeshige; Munetake Yoshitomi; Motohiro Morioka; Yoshinaka Murai; Eiichiro Tanaka
Journal:  Int J Mol Sci       Date:  2013-07-04       Impact factor: 5.923

3.  Xanthine oxidase inhibition by febuxostat attenuates experimental atherosclerosis in mice.

Authors:  Johji Nomura; Nathalie Busso; Annette Ives; Chieko Matsui; Syunsuke Tsujimoto; Takashi Shirakura; Mizuho Tamura; Tsunefumi Kobayashi; Alexander So; Yoshihiro Yamanaka
Journal:  Sci Rep       Date:  2014-04-01       Impact factor: 4.379

4.  Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial.

Authors:  Jie Xu; Yilong Wang; Anxin Wang; Zhiqiang Gao; Xiaoping Gao; Huisheng Chen; Junshan Zhou; Xingquan Zhao; Yongjun Wang
Journal:  Stroke Vasc Neurol       Date:  2019-04-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.